Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L DuPont

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Journal of Addictive Diseases|January 1, 1995
Random drug tests at work: the probability of identifying frequent and infrequent users of illicit drugsR L DuPont, D W Griffin, B R Siskin, et al.
Blood|December 1, 1972
Negative direct Coombs' tests in narcotic addicts receiving maintenance doses of methadoneG K Sherwood, M H McGinniss, R N Katon, et al.
Psychopharmacology Bulletin|October 1, 1982
Animal models of anxiety: implications for research in humansT W Uhde, J P Boulenger, L J Siever, et al.
Anxiety|January 1, 1996
Economic costs of anxiety disordersR L DuPont, D P Rice, L S Miller, et al.
Comprehensive Psychiatry|July 1, 1972
Impact of a multimodality treatment program for heroin addictsB S Brown, R L DuPont, U F Bass, et al.
Journal of Psychiatric Research|January 1, 1990
Sequence of improvement in agoraphobia with panic attacksA Rifkin, J C Pecknold, R P Swinson, et al.
The Journal of Clinical Psychiatry|October 1, 1993
Alprazolam and benzodiazepine dependenceE M Sellers, D A Ciraulo, R L DuPont, et al.
The International Journal of the Addictions|January 1, 1973
Impact of a large-scale narcotics treatment program: a six month experienceB S Brown, R L DuPont, U F Bass, et al.
Journal of Clinical Psychopharmacology|October 1, 1992
Discontinuation of alprazolam after long-term treatment of panic-related disordersR L DuPont, R P Swinson, J C Ballenger, et al.
Archives of General Psychiatry|May 1, 1988
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safetyR Noyes, R L DuPont, J C Pecknold, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Journal of Addictive Diseases|January 1, 1995
Random drug tests at work: the probability of identifying frequent and infrequent users of illicit drugsR L DuPont, D W Griffin, B R Siskin, et al.
Blood|December 1, 1972
Negative direct Coombs' tests in narcotic addicts receiving maintenance doses of methadoneG K Sherwood, M H McGinniss, R N Katon, et al.
Psychopharmacology Bulletin|October 1, 1982
Animal models of anxiety: implications for research in humansT W Uhde, J P Boulenger, L J Siever, et al.
Anxiety|January 1, 1996
Economic costs of anxiety disordersR L DuPont, D P Rice, L S Miller, et al.
Comprehensive Psychiatry|July 1, 1972
Impact of a multimodality treatment program for heroin addictsB S Brown, R L DuPont, U F Bass, et al.
Journal of Psychiatric Research|January 1, 1990
Sequence of improvement in agoraphobia with panic attacksA Rifkin, J C Pecknold, R P Swinson, et al.
The Journal of Clinical Psychiatry|October 1, 1993
Alprazolam and benzodiazepine dependenceE M Sellers, D A Ciraulo, R L DuPont, et al.
The International Journal of the Addictions|January 1, 1973
Impact of a large-scale narcotics treatment program: a six month experienceB S Brown, R L DuPont, U F Bass, et al.
Journal of Clinical Psychopharmacology|October 1, 1992
Discontinuation of alprazolam after long-term treatment of panic-related disordersR L DuPont, R P Swinson, J C Ballenger, et al.
Archives of General Psychiatry|May 1, 1988
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safetyR Noyes, R L DuPont, J C Pecknold, et al.
Pageof 10